Licensed options include
2023 data have shown that pharmaceutical companies have spent over $1 billion on advertisements for weight loss and diabetes medications, which is up 51% from the previous year
Nitric Oxide / cGMP Signalling BPC-157 modulates the nitric oxide (NO) / cyclic guanosine monophosphate (cGMP) signalling pathway
Perhaps you have heard of the Fen-Phen debacle
Follow the protocol document included with your order and consult a clinician for medical decisions
Common reasons for denial include: Lack of documented BMI or weight history No record of prior lifestyle interventions or supervised weight loss attempts Medication prescribed for a use not supported by your plan (e.g., weight loss rather than diabetes) How to Improve Your Chances of Approval To improve the likelihood of approval, your provider will typically need to submit: Your current BMI and a record of weight trends Notes documenting prior weight loss attempts (e.g., diet, exercise programs, counseling) A clinical explanation of why medication is needed for your health Any comorbid conditions, such as hypertension, prediabetes, or sleep apnea At OVYVO, we have extensive experience handling prior authorizations